XUND, a Vienna-based healthtech scale-up, secured €6 million in Pre-Series A funding to boost its expansion in Europe, focusing on digital health solutions.

Information on the Target

XUND, a healthtech scale-up based in Vienna, specializes in developing industry-leading Software as a Medical Device (SaMD). The company has recently completed a €6 million Pre-Series A funding round aimed at amplifying its growth across Europe, particularly focusing on its key markets in the DACH region and the UK. With a growing portfolio of MDR-certified SaMD solutions, XUND aims to cement its status as a prominent player in the European digital health sector.

As the demand for AI-powered medical devices rises across Europe, XUND is poised for significant expansion. The company plans to leverage its certified technology to enable digital interactions from prevention through diagnosis, solidifying its foothold in the evolving landscape of healthcare.

Industry Overview in Austria

The healthcare industry in Austria is increasingly embracing digital innovation, underscored by supportive national policies aimed at enhancing healthcare delivery through technology. As